Cetera Investment Advisers Purchases 2,997 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Cetera Investment Advisers raised its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 10.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,168 shares of the company's stock after purchasing an additional 2,997 shares during the quarter. Cetera Investment Advisers' holdings in HCA Healthcare were worth $11,116,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in HCA. Avantax Advisory Services Inc. raised its position in HCA Healthcare by 0.4% during the first quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company's stock valued at $2,791,000 after purchasing an additional 32 shares in the last quarter. Catalyst Financial Partners LLC increased its holdings in shares of HCA Healthcare by 4.3% during the first quarter. Catalyst Financial Partners LLC now owns 872 shares of the company's stock worth $301,000 after buying an additional 36 shares in the last quarter. Perigon Wealth Management LLC increased its holdings in shares of HCA Healthcare by 2.3% during the first quarter. Perigon Wealth Management LLC now owns 1,797 shares of the company's stock worth $621,000 after buying an additional 40 shares in the last quarter. Barden Capital Management Inc. increased its holdings in shares of HCA Healthcare by 1.4% during the first quarter. Barden Capital Management Inc. now owns 2,921 shares of the company's stock worth $1,009,000 after buying an additional 41 shares in the last quarter. Finally, PCG Wealth Advisors LLC increased its holdings in shares of HCA Healthcare by 3.4% during the first quarter. PCG Wealth Advisors LLC now owns 1,284 shares of the company's stock worth $444,000 after buying an additional 42 shares in the last quarter. Institutional investors own 62.73% of the company's stock.

Analysts Set New Price Targets

Several brokerages recently weighed in on HCA. Wolfe Research cut shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday. Royal Bank Of Canada set a $401.00 price objective on shares of HCA Healthcare and gave the stock an "outperform" rating in a research note on Monday. Truist Financial boosted their price objective on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research note on Wednesday, July 16th. Bank of America cut shares of HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price target on the stock. in a research report on Wednesday, July 16th. Finally, Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Nine equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $396.46.

Insiders Place Their Bets

In related news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer directly owned 12,646 shares of the company's stock, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.30% of the company's stock.

HCA Healthcare Stock Up 0.8%

Shares of HCA traded up $2.85 on Friday, reaching $356.84. The company's stock had a trading volume of 1,369,756 shares, compared to its average volume of 1,559,973. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The stock has a market capitalization of $85.84 billion, a PE ratio of 15.00, a PEG ratio of 1.11 and a beta of 1.39. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The firm has a fifty day moving average of $371.06 and a 200-day moving average of $346.78.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating the consensus estimate of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company's revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter last year, the business posted $5.50 EPS. Equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.8%. HCA Healthcare's dividend payout ratio (DPR) is 12.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.